The Gut Microbiota for Health (GMFH) World Summit is organized by the American Gastroenterological Association (AGA) and the European Society of Neurogastroenterology and Motility (ESNM).
The 2022 GMFH World Summit was the tenth edition of the meeting, which took place on March 12 & 13, 2022, at the Renaissance Washington, D.C. Downtown Hotel (U.S.). The meeting focused on personalized approaches to shaping the gut microbiome. The program was developed by a committee of leading experts, led by co-chairs Gail Hecht, MD, MS, AGAF (Loyola University Medical Center, Chicago, Illinois, U.S.) and Harry Sokol, MD, PhD (Sorbonne University, Paris, France).
The recorded portion of the agenda includes two keynote lectures and four plenary sessions.CME credits are not available for the on-demand recordings.
If you already enrolled or purchased this course, please log into My Courses and launch "2022 Gut Microbiota for Health World Summit"
Faculty:
- Gail Hecht, MD, MS, AGAF, Co-chair, Loyola University Medical Center, Chicago, Illinois
- Harry Sokol, MD, PhD, Co-chair, Sorbonne University, Paris, France
- Purna Kashyap, MBBS, Speaker, Mayo Clinic, Rochester, Minnesota
- Dan Knights, PhD, Speaker, University of Minnesota, Minneapolis,
- Rachel Carmody, PhD, Speaker, Harvard University, Cambridge, Massachusetts
- Gary D. Wu, MD, Speaker, University of Pennsylvania School of Medicine, Philadelphia
- Nicola Segata, PhD, Speaker, University of Trento, Italy
- Emeran Mayer, MD, Speaker, University of California Los Angeles
- Dirk Haller, PhD, Speaker, Technical University of Munich, Germany
- Paul Feuerstadt, MD, Speaker, Yale-New Haven Hospital, Connecticut
- Sahil Khanna, MD, Speaker, Mayo Clinic, Rochester, Minnesota
- Kenya Honda, MD, PhD, Speaker, Keio University School of Medicine, Tokyo, Japan
- Jennifer A. Wargo, MD, MMSc, Speaker, MD Anderson Cancer Center, Houston, Texas
- Eric Alm, PhD, Speaker, Massachusetts Institute of Technology, Cambridge, Massachusetts
- Philippe Langella, PhD, Speaker, National Institute for Agriculture, Food and Environment, Paris, France
- A. Sloan Devlin, PhD, Speaker, Harvard Medical School, Cambridge, Massachusetts
- Siew C. Ng, MD, Speaker, Chinese University of Hong Kong
Pricing
Agenda
| Agenda |
|---|
Keynote Lecture
The promise of the gut microbiome as part of
individualized treatment strategies
Purna Kashyap, MBBS, Mayo Clinic |
Plenary Session 1: Impact of Diet on the Human Gut
Microbiome |
|---|
Moderator: Gary D. Wu, MD, University of Pennsylvania School of
Medicine |
Effect of diet and immigration on microbiome variation
Dan Knights, PhD, University of Minnesota |
Effect of cooking on the microbiome
Rachel Carmody, PhD, Harvard University |
Metabolome patterns in response to diet –
impact of microbiome
Gary D. Wu, MD, University of Pennsylvania School of Medicine |
Plenary Session 2: Gut Microbiota in Precision Medicine |
|---|
Moderator: Giovanni Barbara, MD, University of Bologna (Italy) |
Precision nutrition and the human microbiome
Nicola Segata, PhD, University of Trento (Italy) |
Brain-gut axis in functional gastrointestinal disorders
Emeran Mayer, MD, UCLA |
Circadian rhythm and gut microbiome signatures in type 2 diabetes
Dirk Haller, PhD, Technical University of Munich (Germany |
Ferring Pharmaceuticals, Inc. Product Theater:
The Power of the Microbiome –
Can it be unlocked to break the cycle of recurrent Clostridioides difficile infection?
Paul Feuerstadt, MD, Yale-New Haven Hospital |
Plenary Session 3: Update on Microbiota-based Therapies |
|---|
Moderator: Colleen R. Kelly, MD, Alpert Medical School of Brown University |
Status of commercial stool-based therapies
Sahil Khanna, MD, Mayo Clinic |
Defined microbial communities
Kenya Honda, MD, PhD, Keio University School of Medicine (Japan) |
Microbiota as a modulator of cancer therapy
Jennifer A. Wargo, MD, MMSc, MD Anderson Cancer Center |
Plenary Session 4: Probiotics – Outlook for the Future |
|---|
Moderator: Purna Kashyap, MBBS, Mayo Clinic |
Rational selection of microbes as probiotics
Eric Alm, PhD, Massachusetts Institute of Technology (IN PERSON) |
Genetically engineered bacteria and synthetic bacteria as probiotics
Philippe Langella, PhD, INRA (France) (IN PERSON) |
Microbiota-derived small molecules as probiotics
A. Sloan Devlin, PhD, Harvard Medical School (IN PERSON) |
Closing Lecture
COVID-19, the GI Tract, and the Microbiome: What Do We Know Today?
Siew C. Ng, MD, Chinese University of Hong Kong |
Sponsors:
The 2022 GMFH World Summit is made possible by sponsorships from Danone (Gold Supporter), Ferring Pharmaceuticals, Inc. (Gold Supporter), Aimmune Therapeutics & Seres Therapeutics (Silver Supporter), Sanofi (Silver Supporter), and Intrinsic Medicine, Inc. (Basic Supporter). Additional support is provided by educational grants from Ferring Pharmaceuticals, Inc. and Salix Pharmaceuticals.